Data completeness
0/8 — Limited
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRO-BANTHINE (propantheline bromide) is an anticholinergic agent delivered via injection for symptomatic relief of various gastrointestinal and genitourinary conditions. The drug works by blocking acetylcholine receptors to reduce smooth muscle spasms and secretions. It is positioned as a non-selective parasympatholytic for acute or adjunctive use in disorders requiring reduced GI motility or urinary frequency.
Pre-Launch
Pre-launch status indicates formation of launch teams; team size and budgets depend on Pfizer's strategic prioritization of this injectable repositioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PRO-BANTHINE offers exposure to a classic small-molecule repositioning and injectable market dynamics within a large pharma environment. The pre-launch phase provides opportunity to shape brand strategy and establish competitive positioning, though long-term career stability depends on market adoption and patent durability.
Brand ManagerProduct Manager
Worked on PRO-BANTHINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.